Increased serum interleukin 6 levels in patients with myelodysplastic syndromes
- 1 June 1992
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 16 (6-7) , 585-588
- https://doi.org/10.1016/0145-2126(92)90006-s
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effects of Interleukin‐6 and Granulocyte Colony‐stimulating Factor on the Proliferation of Leukemic Blast Progenitors from Acute Myeloblastic Leukemia PatientsJapanese Journal of Cancer Research, 1990
- Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma.The Journal of Experimental Medicine, 1989
- Response patterns of purified myeloma cells to hematopoietic growth factorsBlood, 1989
- Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemiaBlood, 1989
- Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6Blood, 1989
- Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-1 alphaBlood, 1988
- Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomasNature, 1988
- Human preleukaemia: do we have a model?British Journal of Cancer, 1987
- The myelodysplastic syndromesScandinavian Journal of Haematology, 1986
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982